Our results are consistent with previous reports showing that months after COVID-19, CD8+ T cells are activated and expressing a cytotoxic profile, with increased expression of perforin and granzymes, which may be related to patients’ long-term outcome60,92. The gene discussed is CD8A; the disease is COVID-19.